Advanced search×

Gene therapy for haemophilia.

Baillieres Clin Haematol 9(2):305-17 (1996) PMID 8800507

DOI: 10.1016/S0950-3536(96)80065-5
Version: za2963e q8za6 q8zb1 q8zc4 q8zd0 q8ze5 q8zf0 q8zg2

Similar articles you may find interesting…

  1. Challenges of rare disease research: limited patients and competing priorities.

    Haemophilia 18(3):e192-4 (2012) PMID 21910791

    We achieve in this ongoing process will hopefully not only enable clinical trials research in a rare disease, but also in many medical genetic disease of the future....
  2. Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven^(R)) therapy in haemophilia a patients

    Thromb Res Suppl 126(2):6 (2010) PMID 20542542

    There is no established laboratory method that can predict the most optimal dose of bypassing agents for treatment of haemophilia A. The objectives of the study was to develop an assay that can a) differentiate between the haemostatic capacity in blood from healthy individuals and se...
  3. Special lectures in haemophilia management.

    Haemophilia (2010) PMID 20590852

    SUMMARY: During the last two decades major advances have been achieved in the management of haemophilia. Modern approaches aimed at preventing the recurrent bleedings and their sequelae have been widely adopted. Major challenges of intensive treatment regimens employed today, such a short half life...